NgoNovemba 11, i-PATH kanye ne-United Nations Children’s Fund (UNICEF) babambe i-Global COVID-19 Vaccine Syringe Industry Convening ehlanganisa abakhiqizi besirinji abahamba phambili emhlabeni kanye nezinhlangano zamazwe ngamazwe ukwenza lula ukwanda obala emakethe yesirinji ye-AD ukusiza. ukuhlinzeka ngosizo lwemithi yokugomela i-COVID-19 kanye nokugoma okuvamile. Abakhiqizi baqinisekise izinselelo ezibucayi zokuhlinzeka ngesirinji ye-AD yomhlaba wonke kusukela ekupheleni kuka-2021 kuze kube maphakathi no-2022, naphezu kokuphindaphinda kathathu ukukhiqizwa kwabo nemizamo yezinhlangano zamazwe ngamazwe zokuvikela imijovo ye-AD eyengeziwe emazweni anemali engenayo ephansi naphakathi ayidingayo.
Ukukhuphuka okucatshangelwayo kwesidingo samasirinji emijovo yokugomela i-COVID-19, okulinganiselwa ukuthi ingaphezu kwezigidigidi ezine ukusuka ekupheleni kuka-4 kuya maphakathi no-2021, kungenxa yokuhlinzwa okulindelekile kokulethwa komthamo wokugomela i-COVID-2022 emazweni ezayo nge-COVAX, enkulu. iminikelo evela kohulumeni, kanye nezivumelwano zamazwe amabili. Ngokusekelwe kudatha yomhlaba wonke yokunikezwa nesidingo, imodeli ye-PATH ilinganisela igebe lomhlaba wonke lamasirinji e-AD ayizigidi eziyizinkulungwane eziyi-19.
Izingozi zokuhlinzekwa kwesirinji njengemikhawulo yokuthumela ngaphandle kwezwe, ukubambezeleka kokuthunyelwa kwemikhumbi, imigqa emisha yokukhiqiza ehluleka ukuthola ukufaneleka kwe-World Health Organization (WHO), noma ukubambezeleka ekuqedeni ukwanda kokukhiqiza okuhleliwe kunganwebisa igebe elikhulayo libe ngaphezu kwezigidigidi ezi-2 ngalesi sikhathi. Imithamo ye-booster ingadala ingcindezi eyengeziwe yesidingo emakethe.
Ukugonywa kwenziwa kuphela ngemijovo ye-AD emazweni acishe abe ngu-70, futhi amazwe angu-30 ayisebenzisela ukugoma okuthile. Kusukela ngo-1999, i-WHO, i-UNICEF, kanye ne-United Nations Population Fund baye batusa ukusetshenziswa kwemijovo ye-AD kuphela emhlabeni wonke ukuze kugonywe njengoba “ibonisa ingozi ephansi kakhulu yokudluliselwa kwezifo ezithathelwana ngegazi njengesifo sokusha kwesibindi kohlobo B noma i-HIV” ngoba izinaliti zesirinji ze-AD azikwazi ukususwa noma ziphinde zisetshenziswe.
Okubalulekile, yonke imijovo ye-AD inikeza imithamo engashintshi, okusho ukuthi ingagcwaliswa kuphela ngenani eliqondile lomthamo owodwa wokugoma. Imithi eminingi yokugoma, okuhlanganisa naleyo yokugoma okuningi okubalulekile kwezingane, isetshenziswa kusetshenziswa umthamo wedosi ongu-0.5-mL kanye nesipetu se-AD esimeshayo. Izithiyo zezinto ezihambisana nokuletha imijovo ye-AD zandile ngokuthuthuka komuthi wokugoma, njengokutholakala kwesilinganiso esikhulu sakamuva somuthi wokugomela i-Pfizer odinga isipesheli esikhethekile se-low-dead-dead 0.3-mL AD, esingakaze senziwa ngaphambilini. Osayizi abasha bamasirinji baphambukisa imigqa yokukhiqiza ekukhiqizeni amasirinji ajwayelekile e-AD futhi bangezelele ezinseleleni zokuqhathanisa imithamo yokugoma enosayizi olungile wesirinji lapho kugonywa khona.
Izindlela zokuvala izikhala ezingaba khona ukuze kusheshiswe ukufinyelela, ukunciphisa ukubambezeleka, ukuthuthukisa ukuphepha, kanye nokwakha ukunikezwa okuzinzile kuhlanganisa:
• Nweba umthamo wokukhiqiza ngokutshala imali okunezinhloso kanye nezinzuzo zokwakha ukunikezwa okusimeme nokunciphisa ukubambezeleka kokuthunyelwa kwemikhumbi: Abaxhasi, abatshalizimali, nohulumeni bangasebenzisa amathuluzi asetshenziselwa ukugqugquzela abahlinzeki bemithi yokugoma, okuhlanganisa izibonelelo, imalimboleko engekho noma enenzalo ephansi, kanye neziqinisekiso zomthamo susa ubungozi obuthile kubahlinzeki. Kubaluleke kakhulu ukwandisa ukukhiqizwa kwesirinji kwasekhaya e-Afrika nase-Latin America, lapho kunesisekelo sokuhlinzeka esilinganiselwe kanye nezikhathi ezinde zokuthumela zokulethwa phesheya kwezilwandle.
• Hlola kabusha izimo zokusetshenziswa: Kuze kube yilapho ukushoda kwesirinji se-AD sekuxazululiwe, amazwe akwazi ukusebenzisa ezinye izinhlobo zamasirinji okuphepha angasiza ukulondoloza ukunikezwa kwesirinji ye-AD emazweni anezinhlelo zezempilo ezibambekile.
• Ukulinganisa umthamo wamavolumu womuthi wokugoma: Uma abakhiqizi bemithi yokugoma bengakha imithi yokugoma emisha ye-COVID-19, izikhuthazi, kanye nemithamo yezingane ukuze ifane nemijovo ye-AD yomthamo ongashintshiwe, izoqondisa imisebenzi, ukukhiqiza, nemikhankaso yokugoma.
• Gwema imikhawulo kazwelonke yokuthumela ngaphandle ephinde ibe nomkhawulo wokuhlinzeka: Amazwe anekhono lokukhiqiza isirinji angasiza ukubhekana nezikhala zokuhlinzekwa komhlaba wonke ukuze kuhlangatshezwane nomgomo wokugoma ongamaphesenti angama-70.
I-PATH izoqhubeka nokuqapha imakethe, ngezibuyekezo ezilindelwe zedatha ngo-2022 uma kukhona izinguquko ezibalulekile. Ukumodela okwedlule kwe-PATH okukhishwe ngo-December 2020 kukhombe ubungozi obuyinhloko, okuhlanganisa ukungaqiniseki kwesidingo kanye nesikhathi, ukuthunyelwa kwempahla, kanye nezingqinamba zokugcinwa kwempahla.
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- On November 11, PATH and the United Nations Children’s Fund (UNICEF) held a Global COVID-19 Vaccine Syringe Industry Convening bringing together more than two dozen of the world’s leading syringe manufacturers and multilateral organizations to facilitate increased transparency around the AD syringe market to help bolster supply for COVID-19 vaccines as well as routine immunization.
- The projected spike in demand for syringes for COVID-19 vaccines, estimated to total more than 4 billion from the end of 2021 to mid-2022, is due to the anticipated surge in COVID-19 vaccine dose deliveries to countries coming through COVAX, large donations from governments, and bilateral deals.
- New sizes of syringes divert production lines from producing standard AD syringes and add to the challenges of matching vaccine doses with the correct size of syringe at the point of immunization.
